JCCT127 – Phase III Oral Investigational Drug Trial
Participants must meet the following criteria
- Males and Females, ages 65+ with asthma or congestive heart failure (CHF)
- Generally healthy males and females, ages 85+
- 9 Outpatient Visits & 1 Telephone Contact
- If you qualify, you will receive all study-related medical care at no cost and may be reimbursed for time and travel expenses related to study visits.